Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

China flag China · Delayed Price · Currency is CNY
53.00
+1.00 (1.92%)
At close: Jun 2, 2026
Market Cap9.21B +96.5%
Revenue (ttm)1.54B +14.6%
Net Income174.25M -17.3%
EPS1.00 -47.1%
Shares Out 173.73M
PE Ratio52.81
Forward PEn/a
Dividend0.31 (0.59%)
Ex-Dividend DateMay 26, 2026
Volume3,451,357
Open51.67
Previous Close52.00
Day's Range51.16 - 53.78
52-Week Range26.82 - 84.62
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateJul 24, 2026

About SHE:301617

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in four segments: Iodine Derivatives, Industrial Catalysts (precious metals), Organosilicon Series, and Chemiluminescent Materials. The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodate, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, tris(dioxa-3,6-h... [Read more]

Industry Industrial Inorganic Chemicals
Founded 2008
Employees 748
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301617
Full Company Profile

Financial Performance

In 2025, SHE:301617's revenue was 1.46 billion, an increase of 10.30% compared to the previous year's 1.33 billion. Earnings were 172.29 million, a decrease of -19.05%.

Financial Statements